A new ACC/AHA clinical practice guideline on managing adults with congenital heart disease updates its 2018 recommendations by integrating evidence from 2017 to 2024 and emphasizing specialized...
A large real-world cohort study presented at 67th ASH Annual Meeting and Exposition examined whether adding low-dose aspirin to warfarin improves outcomes in patients with antiphospholipid syndrome and...
A large systematic review and meta-analysis published in the Journal of the American Heart Association evaluated evidence from 155 studies worldwide, identifying strong associations between several viral...
A new multicenter randomized clinical trial published in JAMA evaluated whether consuming caffeinated coffee affects the recurrence of atrial fibrillation (AF) after cardioversion. The findings suggest that...
A national analysis presented at the 2025 AHA Scientific Sessions found that patients with HIV hospitalized with cardiac implantable electronic device–related infective endocarditis had significantly lower...
A phase 2 clinical trial found that ataciguat, a soluble guanylate cyclase activator, may slow aortic valve calcification and help preserve cardiac function in patients with moderate calcific aortic valve...
An artificial intelligence–enabled electrocardiogram (AI-ECG) accurately detected diastolic dysfunction and elevated filling pressure in patients with hypertrophic cardiomyopathy and cardiac amyloidosis,...
A large U.S. cohort study presented at the American Heart Association Scientific Sessions found that middle-aged adults with low HDL cholesterol levels ( 50 mg/dL) faced a 33% higher risk of developing...
As the clinical use of GLP-1 receptor agonists (RA) expands beyond diabetes and obesity, clinicians must balance emerging cardiometabolic and organ-specific benefits with the challenges of persistent...
Late-window alteplase improved 90-day independence in perfusion-selected ischemic stroke, with higher symptomatic intracranial hemorrhage and no mortality difference.
